Experimental Research on the Effect of Ginsenoside Rb1 in Curing Rats with Spinal Cord Ischemia-reperfusion Injury

DOI

10.2991/bbe-16.2016.21How to use a DOI?

Keywords

Spinal cord ischemia-reperfusion injury, Ginsenoside Rb1, Nerve injury

Abstract

Spinal cord ischemia-reperfusion injury (SCII), which was proposed by Allen in 1911, is the secondary damage of primary spinal cord injury and the main reason resulting in nerve injury complication and sequela [1]. Ginsenoside is one of the ingredients of Ginseng and the monomer composition being purified at present reached over 50 types[2-3]. The existing research proves that Ginsenoside Rb1 can play a significant role in neuro protection by alleviating oxygen radical generated from brain injury and lowering calcium influx. In this way, cerebral ischemia-reperfusion injury can be alleviated, but few researches are found in terms of spinal cord ischemia-reperfusion injury[4-6].

Copyright

© 2016, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Boyin Zhang
AU  - Dongxu Zhao
AU  - Chunyang Meng
PY  - 2016/07
DA  - 2016/07
TI  - Experimental Research on the Effect of Ginsenoside Rb1 in Curing Rats with Spinal Cord Ischemia-reperfusion Injury
BT  - Proceedings of the 2016 International Conference on Biomedical and Biological Engineering
PB  - Atlantis Press
SP  - 123
EP  - 129
SN  - 2468-5747
UR  - https://doi.org/10.2991/bbe-16.2016.21
DO  - 10.2991/bbe-16.2016.21
ID  - Zhang2016/07
ER  -